Hansoh Pharmaceutical Group
$34.02Change from previous close: −3.63%Absolute change: −$1.28
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $206.01B
- Enterprise value
- $180.86B
- P/E (trailing 12 months)
- 26.3
- Forward P/E
- 25.8
- Price/book
- 4.67
- Price/sales
- 13.0
- EV/EBITDA
- 28.7
- EV/revenue
- 11.4
Profitability and growth
- Gross margin
- 90.5%
- Operating margin
- 44.4%
- Net margin
- 42.0%
- ROE
- 19.4%
- ROA
- 9.1%
- Revenue growth (year over year)
- 11.7%
- Earnings growth (year over year)
- 33.2%
Financial health
- Total cash
- $37.38B
- Total debt
- $4.23B
- Debt/equity
- 0.11
- Current ratio
- 4.88
- Quick ratio
- 4.78
Dividends
- Annual dividend per share
- $0.49
- Dividend yield
- 1.4%
- Payout ratio
- 35.0%
- Ex-dividend date
- September 22, 2026
Analysts and estimates
- Average price target
- $47.77
- Median price target
- $48.29
- High price target
- $55.20
- Low price target
- $37.34
- Analysts with a price target
- 24
- Consensus
- Strong buy
- Forward EPS
- $1.32
- EPS estimate, current year
- $1.07
Shares and trading
- Beta
- 0.56
- Average volume
- 11.86M
- Shares outstanding
- 6.06B
- Float
- 1.24B
- Institutional ownership
- 12.8%
- Insider ownership
- 79.6%